Core Viewpoint - The company has announced the public disclosure of the list of incentive objects for the 2025 Restricted Stock Incentive Plan, confirming compliance with relevant regulations and the absence of objections during the public notice period [1][2][4][8]. Group 1: Public Disclosure of Incentive Plan - The company held a board meeting on September 19, 2025, to approve the draft of the 2025 Restricted Stock Incentive Plan [1][10]. - The public notice period for the incentive objects was from September 30, 2025, to October 14, 2025 [3]. - The public notice was conducted internally, allowing employees to provide feedback through various channels, with no objections received [4][5]. Group 2: Verification of Incentive Objects - The board's remuneration and assessment committee verified the list of incentive objects against their qualifications, ensuring compliance with the management regulations and listing rules [5][6]. - The incentive objects include core management personnel and key staff, excluding directors, senior management, and significant shareholders [7][8]. - The committee confirmed that the basic information of the incentive objects is accurate and meets the conditions set forth in the management regulations [7][8]. Group 3: Insider Information Compliance - The company conducted a self-inspection regarding insider trading by individuals with knowledge of the incentive plan, confirming no trading activities occurred during the specified period [10][11]. - All insider information handlers were registered, and confidentiality measures were implemented to prevent information leakage [12]. - The self-inspection concluded that there were no violations of insider trading regulations related to the incentive plan [12].
辽宁何氏眼科医院集团股份有限公司董事会薪酬与考核委员会关于2025年限制性股票激励计划激励对象名单的公示情况说明及核查意见